A Mobile Lifestyle Management Program (GlycoLeap) for People With Type 2 Diabetes: Single-Arm Feasibility Study
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
BACKGROUND Singapore’s current prevalence of diabetes exceeds 13.6%. Although lifestyle modification can be effective for reducing the risks for complications of type 2 diabetes mellitus (T2DM), traditional lifestyle interventions are often difficult to administer in the primary care setting due to limited resources. Mobile health apps can address these limitations by offering low-cost, adaptable, and accessible platforms for disseminating lifestyle management interventions. OBJECTIVE Using the RE-AIM evaluation framework, this study assessed the potential effectiveness and feasibility of GlycoLeap, a mobile lifestyle management program for people with T2DM, as an add-on to standard care. METHODS This single-arm feasibility study recruited 100 patients with T2DM and glycated hemoglobin (HbA1c) levels of ≥7.5% from a single community health care facility in Singapore. All participants were given access to a 6-month mobile lifestyle management program, GlycoLeap, comprising online lessons and the Glyco mobile phone app with a health coaching feature. The GlycoLeap program was evaluated using 4 relevant dimensions of the RE-AIM framework: (1) reach (percentage who consented to participate out of all patients approached), (2) effectiveness (percentage point change in HbA1c [primary outcome] and weight loss [secondary outcome]), (3) implementation (program engagement as assessed by various participatory metrics), and (4) maintenance (postintervention user satisfaction surveys to predict the sustainability of GlycoLeap). Participants were assessed at baseline and at follow-up (≥12 weeks after starting the intervention). RESULTS A total of 785 patients were approached of whom 104 consented to participate, placing the reach at 13.2%. Four were excluded after eligibility screening, and 100 patients were recruited. Program engagement (implementation) started out high but decreased with time for all evaluated components. Self-reported survey data suggest that participants monitored their blood glucose on more days in the past week at follow-up compared to baseline (P<.001) and reported positive changes to their diet due to app engagement (P<.001) (implementation). Primary outcome data were available for 83 participants. Statistically significant improvements were observed for HbA1c (–1.3 percentage points, P<.001) with greater improvements for those who logged their weight more often (P=.007) (effectiveness). Participants also had a 2.3% reduction in baseline weight (P<.001) (effectiveness). User satisfaction was high with 74% (59/80) and 79% (63/80) of participants rating the app good or very good and claiming that they would probably or definitely recommend the app to others, respectively (maintenance). CONCLUSIONS Although measures of program engagement decreased with time, clinically significant improvements in HbA1c were achieved with the potential for broader implementation. However, we cannot rule out that these improvements were due to factors unrelated to GlycoLeap. Therefore, we would recommend evaluating the effectiveness and cost effectiveness of GlycoLeap using a randomized controlled trial of at least 12 months. CLINICALTRIAL ClinicalTrials.gov NCT03091517; https://clinicaltrials.gov/ct2/show/NCT03091517 (Archived by WebCite at http://www.webcitation.org/77rNqhwRn)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluating the public health impact of health promotion interventions: the RE-AIM framework.
Glasgow, R. E., Vogt, T. M., & Boles, S. M. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.9.1322 · Cited by 7,217 · cited 3×
“Goal of the Study The goal of this study was to assess the potential effectiveness and feasibility of the GlycoLeap program as an add-on to standard care using the RE-AIM evaluation framework [17,18].”
MethodZhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M., Ali, M., Taddei, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00618-8 · Cited by 4,311
The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.
Toobert, D. J., Hampson, S. E., & Glasgow, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.943 · Cited by 2,561
Wing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2415 · Cited by 1,828
The RE-AIM framework: a systematic review of use over time
Gaglio, B., Shoup, J. A., & Glasgow, R. E. (2013) · American Journal of Public Health · doi:10.2105/ajph.2013.301299 · Cited by 1,029 · cited 3×
“Goal of the Study The goal of this study was to assess the potential effectiveness and feasibility of the GlycoLeap program as an add-on to standard care using the RE-AIM evaluation framework [17,18].”
MethodQuinn, C. C., Shardell, M. D., Terrin, M. L., Barr, E. A., Ballew, S. H., & Gruber-Baldini, A. L. (2011) · Diabetes Care · doi:10.2337/dc11-0366 · Cited by 650
Franz, M. J., MacLeod, J., Evert, A., Brown, C., Gradwell, E., Handu, D., Reppert, A., & Robinson, M. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.03.022 · Cited by 349 · cited 1×
“Coaches capitalize on modalities that have been shown to lead to effective behavior change [20,21], including several theoretical frameworks [22-25], and are trained in the nutrition care process [26].”
BackgroundHolmen, H., Torbjørnsen, A., Wahl, A. K., Jenum, A. K., Småstuen, M. C., Årsand, E., & Ribu, L. (2014) · JMIR mHealth and uHealth · doi:10.2196/mhealth.3882 · Cited by 294 · cited 1×
“Effective T2DM apps stress skill building; self-efficacy; and frequent monitoring of blood glucose levels, weight, dietary intake, and physical activity [5-9].”
BackgroundBonoto, B. C., de Araújo, V. E., Godói, I. P., de Lemos, L. L. P., Godman, B., Bennie, M., Diniz, L. M., & Junior, A. A. G. (2017) · JMIR mhealth and uhealth · doi:10.2196/mhealth.6309 · Cited by 294 · cited 2×
“Studies on diabetes self-management mobile app interventions often involved a sample size of less than 100, including controlled trials [8,27].”
BackgroundT2DM Self-Management via Smartphone Applications: A Systematic Review and Meta-Analysis
Cui, M., Wu, X., Mao, J., Wang, X., & Nie, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166718 · Cited by 269 · cited 1×
“Feasibility studies using mobile phone–based lifestyle management interventions for diabetes typically do not observe such large changes [9,11,29,30].”
Background
Cited by
What Works Best to Engage Participants in Mobile App Interventions and e-Health: A Scoping Review
Oakley-Girvan, I., Yunis, R., Longmire, M., & Ouillon, J. S. (2022) · Telemedicine and e-Health · doi:10.1089/tmj.2021.0176 · Cited by 92
Yang, Q., Hatch, D., Crowley, M. J., Lewinski, A. A., Vaughn, J., Steinberg, D., Vorderstrasse, A., Jiang, M., & Shaw, R. J. (2020) · JMIR mHealth and uHealth · doi:10.2196/17730 · Cited by 30
Summers, C., Tobin, S., & Unwin, D. (2021) · JMIR Diabetes · doi:10.2196/25751 · Cited by 19
Glavas, C., Scott, D., Sood, S., George, E. S., Daly, R. M., Gvozdenko, E., de Courten, B., & Jansons, P. (2024) · JMIR Aging · doi:10.2196/53064 · Cited by 19
“Koot et al [43] examined the feasibility of a mobile lifestyle management program (GlycoLeap; Holmusk, Inc) to improve blood glucose monitoring, dietary advice, physical activity, and diabetes self-management in 100 older adults (mean age 54 years) with T2DM for over 6 months.”
BackgroundResult
Metadata
- Authors
- Koot, D., Goh, P. S. C., Lim, R. S. M., Tian, Y., Yau, T. Y., Tan, N. C., & Finkelstein, E. A.
- Venue
- JMIR mHealth and uHealth
- Publisher
- JMIR Publications Inc.
- Published
- 2019-05-24
- Volume
- 7
- Issue
- 5
- Pages
- e12965
- ISSN
- 2291-5222 (ISSN-L)
- OpenAlex
- W2934896681
- Cited by
- 55
- References
- 18
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Mobile Lifestyle Management Program (GlycoLeap) for People With Type 2 Diabetes: Single-Arm Feasibility Study. https://app.cochat.ai/papers/10.2196/12965
- The paper
- Koot, D., Goh, P. S. C., Lim, R. S. M., Tian, Y., Yau, T. Y., Tan, N. C., & Finkelstein, E. A. (2019). A Mobile Lifestyle Management Program (GlycoLeap) for People With Type 2 Diabetes: Single-Arm Feasibility Study. JMIR mHealth and uHealth. https://doi.org/10.2196/12965
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.